Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence

The emergence of hypervirulence (hv) and carbapenem resistance (CR) as distinct evolutionary directions for Klebsiella pneumoniae presents a significant threat in clinical settings. However, in recent years, there has been a growing identification of K. pneumoniae strains that integrate both phenoty...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Chen, Liya Ying, Luying Xiong, Xueting Wang, Ping Lu, Yuan Wang, Ping Shen, Yonghong Xiao
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:hLife
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2949928324000543
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846111755756896256
author Tao Chen
Liya Ying
Luying Xiong
Xueting Wang
Ping Lu
Yuan Wang
Ping Shen
Yonghong Xiao
author_facet Tao Chen
Liya Ying
Luying Xiong
Xueting Wang
Ping Lu
Yuan Wang
Ping Shen
Yonghong Xiao
author_sort Tao Chen
collection DOAJ
description The emergence of hypervirulence (hv) and carbapenem resistance (CR) as distinct evolutionary directions for Klebsiella pneumoniae presents a significant threat in clinical settings. However, in recent years, there has been a growing identification of K. pneumoniae strains that integrate both phenotypes, resulting in severe clinical outcomes. Carbapenem-resistant hypervirulent K. pneumoniae (CRhvKP) typically emerges through the acquisition of plasmids carrying either virulence or CR-encoded genes by carbapenem-resistant K. pneumoniae or hypervirulent K. pneumoniae. Furthermore, the acquisition of a hybrid plasmid can confer a combination of CR and hv. CRhvKP can cause a variety of infections, including pneumonia, urinary tract infections, bloodstream infections, liver abscesses, and other related conditions. While the sequence type 11 (ST11) dominates the majority of CRhvKP strains in China, the molecular factors responsible for the success of ST11 CRhvKP largely remain unknown. Here, we provide an overview of the current understanding of the variation and distribution of crucial virulence determinants, the mechanisms driving the merging of hv and CR, and the potential molecular factors influencing the epidemiological success of ST11 CRhvKP. This research aims to contribute to a comprehensive understanding of the complexities surrounding CRhvKP. It is imperative to underscore the development of combination therapies, precision medicine, and vaccine strategies as pivotal approaches in effectively combating CRhvKP. Considering the widespread prevalence of CRhvKP, a prioritized, multifaceted approach encompassing infection control, active surveillance, and the development of innovative therapeutics is essential.
format Article
id doaj-art-506c2bd7c05f4103a9580d4eb9f8b4d6
institution Kabale University
issn 2949-9283
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series hLife
spelling doaj-art-506c2bd7c05f4103a9580d4eb9f8b4d62024-12-23T04:19:48ZengElsevierhLife2949-92832024-12-01212611624Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergenceTao Chen0Liya Ying1Luying Xiong2Xueting Wang3Ping Lu4Yuan Wang5Ping Shen6Yonghong Xiao7State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaHangzhou Stomatological Hospital, Zhejiang, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China; Jinan Microecological Biomedicine Shandong Laboratory, Shandong, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China; Jinan Microecological Biomedicine Shandong Laboratory, Shandong, China; Correspondence:The emergence of hypervirulence (hv) and carbapenem resistance (CR) as distinct evolutionary directions for Klebsiella pneumoniae presents a significant threat in clinical settings. However, in recent years, there has been a growing identification of K. pneumoniae strains that integrate both phenotypes, resulting in severe clinical outcomes. Carbapenem-resistant hypervirulent K. pneumoniae (CRhvKP) typically emerges through the acquisition of plasmids carrying either virulence or CR-encoded genes by carbapenem-resistant K. pneumoniae or hypervirulent K. pneumoniae. Furthermore, the acquisition of a hybrid plasmid can confer a combination of CR and hv. CRhvKP can cause a variety of infections, including pneumonia, urinary tract infections, bloodstream infections, liver abscesses, and other related conditions. While the sequence type 11 (ST11) dominates the majority of CRhvKP strains in China, the molecular factors responsible for the success of ST11 CRhvKP largely remain unknown. Here, we provide an overview of the current understanding of the variation and distribution of crucial virulence determinants, the mechanisms driving the merging of hv and CR, and the potential molecular factors influencing the epidemiological success of ST11 CRhvKP. This research aims to contribute to a comprehensive understanding of the complexities surrounding CRhvKP. It is imperative to underscore the development of combination therapies, precision medicine, and vaccine strategies as pivotal approaches in effectively combating CRhvKP. Considering the widespread prevalence of CRhvKP, a prioritized, multifaceted approach encompassing infection control, active surveillance, and the development of innovative therapeutics is essential.http://www.sciencedirect.com/science/article/pii/S2949928324000543Klebsiella pneumoniaecarbapenem-resistancehypervirulencevirulence factorsevolutiongenome
spellingShingle Tao Chen
Liya Ying
Luying Xiong
Xueting Wang
Ping Lu
Yuan Wang
Ping Shen
Yonghong Xiao
Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
hLife
Klebsiella pneumoniae
carbapenem-resistance
hypervirulence
virulence factors
evolution
genome
title Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
title_full Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
title_fullStr Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
title_full_unstemmed Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
title_short Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: Key virulence factors and evolutionary convergence
title_sort understanding carbapenem resistant hypervirulent klebsiella pneumoniae key virulence factors and evolutionary convergence
topic Klebsiella pneumoniae
carbapenem-resistance
hypervirulence
virulence factors
evolution
genome
url http://www.sciencedirect.com/science/article/pii/S2949928324000543
work_keys_str_mv AT taochen understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT liyaying understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT luyingxiong understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT xuetingwang understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT pinglu understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT yuanwang understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT pingshen understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence
AT yonghongxiao understandingcarbapenemresistanthypervirulentklebsiellapneumoniaekeyvirulencefactorsandevolutionaryconvergence